Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers in China and frequently occurs with chronic hepatitis B virus infection. To investigate whether cell-based cancer immunotherapy induces tumor specific immune responses in patients with HCC and provides clinical benefits, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yanyan, Wu, Yeting, Yang, Chou, Huang, Jing, Guo, Yabing, Liu, Li, Chen, Ping, Wu, Dongyun, Liu, Junyun, Li, Jin, Zhou, Xiangjun, Hou, Jinlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363021/
https://www.ncbi.nlm.nih.gov/pubmed/28330473
http://dx.doi.org/10.1186/s12967-017-1165-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363021/
https://www.ncbi.nlm.nih.gov/pubmed/28330473
http://dx.doi.org/10.1186/s12967-017-1165-0

Ejemplares similares